← Eichor
Study identifier: NCT05921643 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Short- and Medium-term Evaluation of Mastoid Filling Using Bioactive Glass"

Condition: Cholesteatoma  ·  Sponsor: Centre Hospitalier Intercommunal Creteil

PhaseN/A
Planned participants70
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Adult patients referred to the ENT surgery department of the Hospices Civils de Lyon with cholesteatoma that had never been operated on. All patients will benefit from surgical management for cholesteatoma initially in the operating room under general anesthesia. The surgical technique (closed technique) is the reference technique for the management of cholesteatoma in adults. It involves a cartilaginous removal to reconstruct the attical region. Then a filling material is used to fill the mastoid (GlassBONE™ or Bonalive™), and above all to stabilize the cartilaginous fragment to prevent a recurrence.

This description comes directly from the study's public registry record.

Talk to the study team

Maxime fieux  ·  04.72.66.64.15  ·  maxime.fieux@chu-lyon.fr

Camille JUNG  ·  01 57 02 20 30  ·  camille.jung@chicreteil.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Hôpital Lyon SudLyon, Pierre-Bénite, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05921643